Alemi A, Zavar Reza J, Haghiralsadat F, Zarei Jaliani H, Haghi Karamallah M, Hosseini SA, Haghi Karamallah S (2018) Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy. J Nanobiotechnol 16:1–20
Al-Hussaniy HA, Alburghaif AH, AL-Zobaidy MAHJ, Alkuraishy HM, Mostafa-Hedeab G, Azam F, Al-Samydai AM, Al-tameemi ZS, Naji MA (2023) Chemotherapy-induced cardiotoxicity: a new perspective on the role of Digoxin, ATG7 activators, Resveratrol, and herbal drugs. J Med Life 16(4):491
Article PubMed PubMed Central Google Scholar
Amiri H, Javid H, Einafshar E, Ghavidel F, Rajabian A, Hashemy SI, Hosseini H (2024) Development and evaluation of PLGA nanoparticles surfaced modified with chitosan-folic acid for improved delivery of resveratrol to prostate cancer cells. BioNanoScience: 1-11
Anand U, Dey A, Chandel AKS, Sanyal R, Mishra A, Pandey DK, De Falco V, Upadhyay A, Kandimalla R, Chaudhary A (2022) Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Diseases 10:1367–1401
Article PubMed PubMed Central Google Scholar
Anisimov MN, Korshunova AV, Popov VV, Gudimchuk NB (2023) Microtubule rescue control by drugs and MAPs examined with in vitro pedestal assay. Eur J Cell Biol 102(4):151366
Article CAS PubMed Google Scholar
Barboni L, Lambertucci C, Appendino G, Vander Velde DG, Himes RH, Bombardelli E, Wang M, Snyder JP (2001) Synthesis and NMR-driven conformational analysis of taxol analogues conformationally constrained on the C13 side chain. J Med Chem 44(10):1576–1587
Article CAS PubMed Google Scholar
Belinda De Simone M, Diego U (2023) The management of complicated colorectal cancer in older patients in a global perspective: the CO-OLDER study
Bernabeu E, Cagel M, Lagomarsino E, Moretton M, Chiappetta DA (2017) Paclitaxel: what has been done and the challenges remain ahead. Int J Pharm 526(1–2):474–495
Article CAS PubMed Google Scholar
Bisoyi P (2022) Malignant tumors–as cancer. Elsevier, Understanding Cancer, pp 21–36
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424
Cannariato M, Zizzi EA, Pallante L, Miceli M, Deriu MA (2023) Mechanical communication within the microtubule through network-based analysis of tubulin dynamics. Biomech Model Mechanobiol 23:1–11
Chen S, Song Z, Feng R (2020) Recent development of copolymeric nano-drug delivery system for Paclitaxel. Anti-Cancer Agents Med Chem Formerly Current Medicinal Chemistry-Anti-Cancer Agents 20(18):2169–2189
Deng S, Banerjee S, Chen H, Pochampally S, Wang Y, Yun M-K, White SW, Parmar K, Meibohm B, Hartman KL (2023) SB226, an inhibitor of tubulin polymerization, inhibits paclitaxel-resistant melanoma growth and spontaneous metastasis. Cancer Lett 555:216046
Article CAS PubMed Google Scholar
Ding J, Liu H-X, Xu W, Zhang X-L, Zhao R-X, Cheng X-Y, Chen X-H, Zhou W-J, Zhang R-C, Ma R (2022) Nab-paclitaxel is far superior to traditional paclitaxel
Dubinsky S, Patel D, Wang X, Srikanthan A, Ng TL, Tsang C (2022) Pre-medication protocols for the prevention of paclitaxel-induced infusion related reactions: a systematic review and meta-analysis. Supp Care Cancer 30(7):5627–5644
Ejigah V, Owoseni O, Bataille-Backer P, Ogundipe OD, Fisusi FA, Adesina SK (2022) Approaches to improve macromolecule and nanoparticle accumulation in the tumor microenvironment by the enhanced permeability and retention effect. Polymers 14(13):2601
Article CAS PubMed PubMed Central Google Scholar
El-Far SW, Abo El-Enin HA, Abdou EM, Nafea OE, Abdelmonem R (2022) Targeting colorectal cancer cells with niosomes systems loaded with two anticancer drugs models; comparative in vitro and anticancer studies. Pharmaceuticals 15(7):816
Article CAS PubMed PubMed Central Google Scholar
Fahad AS (2016) Formulation and evaluation of paclitaxel-loaded nanoemulsion for pulmonary administration, University of Toledo
Fang W-S, Liang X-T (2005) Recent progress in structure activity relationship and mechanistic studies of taxol analogues. Mini Rev Med Chem 5(1):1–12
Article CAS PubMed Google Scholar
Feng Y, Jin H, Guo K, Wasan HS, Ruan S, Chen C (2021) Causes of death after colorectal cancer diagnosis: a population-based study. Front Oncol 11:647179
Article PubMed PubMed Central Google Scholar
Fernández Y, Movellan J, Foradada L, Giménez V, García-Aranda N, Mancilla S, Armiñán A, Borgos SE, Hyldbakk A, Bogdanska A (2022) In vivo antitumor and antimetastatic efficacy of a polyacetal-based paclitaxel conjugate for prostate cancer therapy. Adv Healthc Mater 11(7):2101544
Foster JM, Zhang C, Rehman S, Sharma P, Alexander HR (2023) The contemporary management of peritoneal metastasis: a journey from the cold past of treatment futility to a warm present and a bright future. CA A Cancer J Clin 73(1):49–71
Gharbavi M, Sharafi A, Motamed Fath P, Oruji S, Pakzad H, Kheiri Manjili H (2021) Formulation and biocompatibility of microemulsion-based PMBN as an efficient system for paclitaxel delivery. Journal of Applied Biotechnology Reports 8(1)
Han J, Go G, Zhen J, Zheng S, Le VH, Park J-O, Park S (2017) Feasibility study of dual-targeting paclitaxel-loaded magnetic liposomes using electromagnetic actuation and macrophages. Sensors Actuators B Chem 240:1226–1236
Harshita, Barkat MA, Beg S, Pottoo FH, Ahmad FJ (2019) Nanopaclitaxel therapy: an evidence based review on the battle for next-generation formulation challenges. Nanomedicine 14(10): 1323-1341
He Z, Wan X, Schulz A, Bludau H, Dobrovolskaia MA, Stern ST, Montgomery SA, Yuan H, Li Z, Alakhova D (2016) A high capacity polymeric micelle of paclitaxel: implication of high dose drug therapy to safety and in vivo anti-cancer activity. Biomaterials 101:296–309
Article CAS PubMed PubMed Central Google Scholar
Hosokawa M, Ito S, Noda K, Kono Y, Ogawara K-I (2023) Preparation and evaluation of paclitaxel-loaded PEGylated niosomes composed of sorbitan esters. Biol Pharm Bullet 46(10):1479–1483
Icart L, Santos ER, Agüero L, Andrade LR, De Souza C, Avila LD, Zaldivar D, Dias M (2018) Paclitaxel-loaded PLA/PEG/fluorescein anticancer agent prepared by Ugi reaction. Int J Polym Mater Biomater 67(13):776–782
Islami F, Goding Sauer A, Miller KD, Siegel RL, Fedewa SA, Jacobs EJ, McCullough ML, Patel AV, Ma J, Soerjomataram I (2018) Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA a Cancer J Clin 68(1):31–54
Jahan S, Karim ME, Chowdhury EH (2021) Nanoparticles targeting receptors on breast cancer for efficient delivery of chemotherapeutics. Biomedicines 9(2):114
Article CAS PubMed PubMed Central Google Scholar
Jain D, Chumbhale D (2022) HA-PEG-PCL Nanoparticles for targeted delivery of paclitaxel to colon cancer. NeuroQuantology 20(9):5433
Javeed A, Ashraf M, Riaz A, Ghafoor A, Afzal S, Mukhtar MM (2009) Paclitaxel and immune system. Eur J Pharm Sci 38(4):283–290
Article CAS PubMed Google Scholar
Javid H, Oryani MA, Rezagholinejad N, Esparham A, Tajaldini M, Karimi-Shahri M (2024) RGD peptide in cancer targeting: benefits, challenges, solutions, and possible integrin–RGD interactions. Cancer Med 13(2):e6800
Article CAS PubMed PubMed Central Google Scholar
Kapoor-Narula U, Lenka N (2022) Cancer stem cells and tumor heterogeneity: deciphering the role in tumor progression and metastasis. Cytokine 157:155968
Article CAS PubMed Google Scholar
Kaur S, Arora D, Singh A (2020) Mini-review on impact of known drug-drug interactions in cancer patients. Pharmaspire 12:114–116
Kaur V, Singh ASA, Kaur K, Rath G (2020) Targeted based drug delivery system for colon cancer. J Drug Del Ther 10(1):111–122
Khan S, Hossain MK (2022) Classification and properties of nanoparticles. Elsevier, Nanoparticle-based polymer composites, pp 15–54
Kim K-S, Kim SH, Im C-N, Na K, Lee M-Y, Park JK, Kuh H-J (2023) Effect of paclitaxel priming on doxorubicin penetration in a multicellular layer model of human colorectal cancer cells. Biochem Biophys Res Commun 647:30–36
Article CAS PubMed Google Scholar
Kumar A, Khan MN, Kanoujia J, Singh A, Mishra N (2020) Ligand Decorated embelin loaded PLGA nanoparticles for management of alcohol induced hepatotoxicity. J Drug Del Ther 10(1):72–80
Lee JS, Oh H, Sung D, Lee JH, Choi WI (2021) High solubilization and controlled release of paclitaxel using thermosponge nanoparticles for effective cancer therapy. Pharmaceutics 13(8):1150
留言 (0)